Literature DB >> 9690456

Gamma-ray irradiation induces B7.1 costimulatory molecule neoexpression in various murine tumor cells.

A Morel1, N Fernandez, A de La Coste, H Haddada, M Viguier, B S Polla, B Antoine, A Kahn.   

Abstract

The use of gene-modified tumor cells as a strategy for active immunotherapy is currently undergoing intensive fundamental and clinical research. Most clinical trials use gamma-ray-irradiated tumor cells as vaccine, although little is known about the effects of irradiation on the immunogenicity of tumor cells. In particular, no data have been reported so far concerning the effects of gamma-ray irradiation on the expression of B7 molecules in tumor cells. In this paper, we show a neoexpression of the B7.1 molecule after gamma-ray irradiation in tumor cell lines from different tissues, while the B7.2 molecule remains unexpressed in all the cell lines tested. Furthermore, the induction of B7.1 molecule membrane expression after irradiation is shown to result from the neoexpression of B7.1 mRNA, and to be reproduced with H2O2 oxidative stress. These data could explain the enhanced immunogenicity of many tumor cells after irradiation, and could lead to new immunotherapy protocols.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9690456     DOI: 10.1007/s002620050488

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  13 in total

1.  Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation.

Authors:  Maximilian Diehn; Ash A Alizadeh; Oliver J Rando; Chih Long Liu; Kryn Stankunas; David Botstein; Gerald R Crabtree; Patrick O Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-23       Impact factor: 11.205

2.  Neural stem/progenitor cells express costimulatory molecules that are differentially regulated by inflammatory and apoptotic stimuli.

Authors:  Jaime Imitola; Manuel Comabella; Anil K Chandraker; Fernando Dangond; Mohamed H Sayegh; Evan Y Snyder; Samia J Khoury
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

3.  Radiation-induced tumor neoantigens: imaging and therapeutic implications.

Authors:  Christopher D Corso; Arif N Ali; Roberto Diaz
Journal:  Am J Cancer Res       Date:  2011-01-25       Impact factor: 6.166

4.  Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen.

Authors:  Andrew B Sharabi; Christopher J Nirschl; Christina M Kochel; Thomas R Nirschl; Brian J Francica; Esteban Velarde; Theodore L Deweese; Charles G Drake
Journal:  Cancer Immunol Res       Date:  2014-12-19       Impact factor: 11.151

5.  Irradiation up-regulates CD80 expression through induction of tumour necrosis factor-alpha and CD40 ligand expression on B lymphoma cells.

Authors:  Fumio Ishikawa; Hideki Nakano; Akira Seo; Yayoi Okada; Hideko Torihata; Yuriko Tanaka; Tetsuya Uchida; Hidekazu Miyake; Terutaka Kakiuchi
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

6.  Irradiation up-regulates CD80 expression through two different mechanisms in spleen B cells, B lymphoma cells, and dendritic cells.

Authors:  Hideko Torihata; Fumio Ishikawa; Yayoi Okada; Yuriko Tanaka; Tetsuya Uchida; Toru Suguro; Terutaka Kakiuchi
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

7.  Local irradiation of murine melanoma affects the development of tumour-specific immunity.

Authors:  Yu-Pei Liao; Chun-Chieh Wang; Dörthe Schaue; Keisuke S Iwamoto; William H McBride
Journal:  Immunology       Date:  2009-02-17       Impact factor: 7.397

8.  T lymphocytes and normal tissue responses to radiation.

Authors:  Dörthe Schaue; William H McBride
Journal:  Front Oncol       Date:  2012-09-19       Impact factor: 6.244

Review 9.  A Century of Radiation Therapy and Adaptive Immunity.

Authors:  Dörthe Schaue
Journal:  Front Immunol       Date:  2017-04-11       Impact factor: 7.561

10.  Regulatory T cells in radiotherapeutic responses.

Authors:  Dörthe Schaue; Michael W Xie; Josephine A Ratikan; William H McBride
Journal:  Front Oncol       Date:  2012-08-17       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.